NCT03921528: An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
- State
- Completed
- Phase
- Phase 2
- People
- 58 taking part
- Started
- 22 Apr 2019
- Primary completion
- 19 Jan 2021
- Arms
- Cohort 1, Cohort 2, Cohort 3
- Results
- Posted on the registry
- Papers
- doi:10.1212/wnl.0000000000209151
- 19 Apr 2019: Trial registered
- 22 Apr 2019: Trial started
- 17 Nov 2022: Trial results posted
- 28 Feb 2024: Trial completed